Company page

Stevanato Group S.p.a.

Stevanato Group S.p.A. is a public company traded under the ticker STVN in the American market, with a market capitalization of approximately $4.79 billion. The company specializes in providing advanced drug delivery systems and integrated solutions for the pharmaceutical and biotechnology industries. Stevanato Group is recognized for its innovative products and commitment to enhancing patient safety and treatment efficacy.